Recombinant Rat CD19 Fc Chimera Protein, CF Summary
Product Specifications
Rat CD19 (Arg19-Gly287) Accession # NP_001013255.2 | IEGRMDP | Mouse IgG2a (Glu98-Lys330) |
N-terminus | C-terminus | |
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
10525-CD
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 500 μg/mL in PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: CD19
CD19, also known as B4, is a transmembrane glycoprotein of the immunoglobulin superfamily that plays a central role in B cell activation and humoral immune responses (1, 2). CD19 consists of an extracellular domain (ECD) with two C2-type Ig-like domains, a transmembrane segment, and a cytoplasmic domain with nine tyrosine residues, 3 of which are critical for function (1,2). Within the mature ECD, rat CD19 shares 57% and 88% amino acid sequence identity with human and mouse CD19, respectively. CD19 is expressed throughout B cell development from pre‑B cells through mature B cells, and it is commonly used as a B cell lineage marker (1, 2). It is required for the responsiveness of mature B cell to antigen stimulation, germinal center development, and antibody affinity maturation (1, 2). CD19 associates with the B cell antigen receptor (BCR), CD81, CD38, CD21, CD22, and IFITM1/CD225/Leu-13 (1, 3). These associations enable CD19 to amplify B cell signaling and reduce the threshold for antigen stimulation through the BCR (1, 3). CD19 polymorphisms and up-regulation can lead to the development of autoimmunity by promoting autoantibody production (2). CD19+ target cells can be recognized and killed by T cells that express anti-CD19 chimeric antigen receptors (CARs) (4). This interaction has been shown to be beneficial in the treatment of various B-cell malignancies, such as leukemias and lymphomas (4, 5).
- Wang, K. et al. (2012) Exp. Hematol Oncol. 1:36.
- Del Nargo, C.J. et al. (2005) Immunol Res. 31:229.
- Yu, F. et al. (2010) J Neurooncol. 103:187.
- Kochenderfer, J. et al. (2015) J Clin Oncol. 33:540.
- Lee, D. et al. (2015) Lancet. 385:517.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Rat CD19 Fc Chimera Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Rat CD19 Fc Chimera Protein, CF and earn rewards!
Have you used Recombinant Rat CD19 Fc Chimera Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image